Lead Product(s) : Erythritol
Therapeutic Area : Endocrinology
Study Phase : Undisclosed
Sponsor : Cargill
Deal Size : Inapplicable
Deal Type : Inapplicable
Dose-Dependent Effects of Erythritol on Endothelial Function in Type 2 Diabetes Mellitus
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 25, 2013
Lead Product(s) : Erythritol
Therapeutic Area : Endocrinology
Highest Development Status : Undisclosed
Sponsor : Cargill
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Erythritol
Therapeutic Area : Endocrinology
Study Phase : Undisclosed
Sponsor : Cargill
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 31, 2012
Lead Product(s) : Erythritol
Therapeutic Area : Endocrinology
Highest Development Status : Undisclosed
Sponsor : Cargill
Deal Size : Inapplicable
Deal Type : Inapplicable